Company intelligence / Profile preview

Nexilis AG

Zurich, Zurich, Switzerlandnexilis.com ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

Nexilis AG is a Swiss MedTech company focused on developing proprietary medical devices to improve the fixation of implants in patients with poor bone quality. Their technology aims to enhance stability by strengthening the bone at the point of implantation, addressing a significant challenge in orthopedic and trauma surgeries. The company has been active since at least 2016, with ongoing product development led by an experienced team.

Therapeutic areas: Rheumatology
Modalities: DeviceMedical device (implant fixation technology)
Industry: Implantable Medical Devices

Partnerships

Georgiou Enterprises (major investor/supporter)

Beyond the preview

Go deeper on Nexilis AG.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nexilis AG.

Explore the full profile